Business Operations:

Sector: Consumer Defensive
Industry: Household & Personal Products

The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care cleaning and disinfecting products, bleach, clog removers, and laundry additives under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Poett, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; water-filtration products under the Brita brand; and natural personal care products under the Burt's Bees brand in the United States. The International segment provides laundry additives, home care products, bags and wraps, cat litter products, water-filtration systems, professional cleaning and disinfecting products, natural personal care products, food, grilling products, and digestive health products internationally primarily under the Clorox, Glad, Poett, Brita, Burt's Bees, Pine-Sol, Ever Clean, Clorinda, Chux and Fresh Step Brands. It also offers vitamins, minerals, and supplement products under the Natural Vitality, RenewLife, NeoCell, and Rainbow Light brands. The company sells its products through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.

Revenue projections:

With The Clorox Company's revenue forecasted to drop below last year's level, investors are expected to take a cautious stance. Such declines typically affect a company's bottom line, reducing profitability and making investors hesitant to invest heavily in the company until financial performance improves.

Financial Ratios:

currentRatio	0.65800
forwardPE	14.14800
debtToEquity	2221.42900
earningsGrowth	-0.50100
revenueGrowth	-0.02000
grossMargins	0.42321
operatingMargins	0.12885
trailingEps	4.81000
forwardEps	6.15564

The Clorox Company's current ratio of 0.658 highlights that the company may not have sufficient cash reserves and assets to cover its short-term debts. This could lead to liquidity concerns, making it difficult for The Clorox Company to meet its immediate financial obligations.
CLX's Forward PE is positioned well, reflecting a favorable balance between stock price and earnings. The stock isn't overpriced, offering room for growth and making it a potentially rewarding investment as its value has room to rise further.
CLX's high debt-to-equity ratio shows the company is significantly leveraged, relying heavily on debt financing. This raises the potential for increased financial risk, especially if the company's earnings or cash flow are negatively impacted.
CLX's low earnings and revenue growth point to a likely decrease in profits. This suggests that the company is facing financial difficulties and may struggle to maintain its current level of profitability.
The Clorox Company's negative gross and operating margins indicate that the company is operating at a loss. This reflects an inability to cover production costs and operational expenses, which could undermine its financial stability.
CLX's forward EPS being higher than its trailing EPS suggests that the company is expected to generate stronger profits this year. This points to improving financial performance, with CLX anticipated to deliver better earnings than it did in the prior year.

Price projections:

Price projections for CLX have been gradually lowered, signaling reduced optimism among analysts. This downward adjustment suggests that the company may face challenges in meeting previous growth expectations.

Insider Transactions:

1 sales of CLX stock were made, with market price at 124.62999725341797 per share.The Clorox Company stock was bought in 2 transactions, while the market price was at 95.02000045776367.More buys than sells near the current price levels of The Clorox Company might signal a favorable outlook for the stock. Investors seem to be showing confidence by purchasing more, potentially expecting positive future performance.

Recommendation changes over time:

Analysts have developed a sell bias for CLX, indicating potential caution for investors. However, it's important to base decisions on a broader set of market indicators to gain a more complete understanding of CLX's future and avoid reacting solely to the analysts' negative sentiment.